Zobrazeno 1 - 10
of 174
pro vyhledávání: '"H. De Cremoux"'
Autor:
B. Dakhil, V. Oltean, A. Ben Abdesselam, Patrick Bagan, Jean Claude Couffinhal, C. Raynaud, H. De Cremoux
Publikováno v:
Revue des Maladies Respiratoires. 30:414-419
Resume Introduction L’interet d’une rehabilitation avant chirurgie pour carcinome pulmonaire reste a definir. Le but de cette etude observationnelle a ete d’evaluer les benefices d’une rehabilitation associee a une ventilation non invasive ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0c32b69fc2443d337e4fa3cb155c3f6
https://doi.org/10.1016/j.rmr.2012.12.004
https://doi.org/10.1016/j.rmr.2012.12.004
Autor:
T. Le Chevalier, R. Arriagada, F. Thomas, P. Baldeyrou, P. Ruffie, H. de Cremoux, M. Martin, M. L. Cerrina, H. De Th�, M. Tarayre, H. Sancho-Garnier, null and the GROP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a309767fceb1115a3ecc37c9269c0fd4
https://doi.org/10.1159/000416202
https://doi.org/10.1159/000416202
Autor:
Y. Yataghene, O. Rixe, E. Brain, J.L. Misset, M. Bekradda, Patrick Soulié, H. de Cremoux, J. C. Saltiel, Isabelle Monnet, Esteban Cvitkovic, Sabine Saltiel-Voisin
Publikováno v:
Annals of Oncology. 13:103-107
Background Oxaliplatin and vinorelbine are both active agents against non-small-cell lung cancer (NSCLC). In a previous phase I trial, we showed that oxaliplatin (130 mg/m2, day 1) and vinorelbine (26 mg/m2/day, days 1 and 8) can be safely combined w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aac3f2637348e47d305ef8400431ccfc
https://doi.org/10.1093/annonc/mdf006
https://doi.org/10.1093/annonc/mdf006
Autor:
Patrick Soulié, J. Gastiaburu, J.P. Armand, S. Brienza, F. Hugret, J. C. Saltiel, S. Voisin, H. de Cremoux, Isabelle Monnet, Esteban Cvitkovic
Publikováno v:
European Journal of Cancer. 34:1124-1127
The aim of this phase II study was to determine the antitumour activity and safety of trans-1-diaminocyclohexane-platinum (oxaliplatin) in previously untreated advanced non-small cell lung cancer (NSCLC) patients. 33 patients with unresectable and me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3687e446dc3c40feab2b69eb3052a3a
https://doi.org/10.1016/s0959-8049(98)00007-0
https://doi.org/10.1016/s0959-8049(98)00007-0
Autor:
F Verra, H. De Cremoux, Jean-François Bernaudin, François Lebargy, Jean Bignon, Estelle Escudier
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 151:630-634
Although respiratory changes induced by tobacco smoke have been extensively described, no study has focused on ciliary abnormalities associated with chronic smoking. Ciliary ultrastructure was studied in 37 adults with chronic sputum production (CSP)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09e18dacd413b0454e3f150f1a8ab94e
https://doi.org/10.1164/ajrccm/151.3_pt_1.630
https://doi.org/10.1164/ajrccm/151.3_pt_1.630
Autor:
J. C. Saltiel, E. Quoix, Pierre Ruffié, H. de Cremoux, Isabelle Monnet, Patrick Chariot, S. Voisin, T. Le Chevalier
Publikováno v:
Annals of Oncology. 3:813-817
Two chemotherapy regimens for patients with extensive small-cell lung cancer were prospectively compared in a randomized multicentric trial with crossover. Every four weeks, 60 consecutive previously untreated patients received either DPE (doxorubici
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57a134ad72fcd7dfb5689b4a3f241778
https://doi.org/10.1093/oxfordjournals.annonc.a058101
https://doi.org/10.1093/oxfordjournals.annonc.a058101
Autor:
C. Chlecq, Evani Viegas-Péquignot, Jean Bignon, H. De Cremoux, Bernard Dutrillaux, A. Flüry-Herard
Publikováno v:
Cancer Genetics and Cytogenetics. 59:1-8
The cytogenetic study of five cases of untreated adenosquamous carcinoma of the lung allows us to propose a number of characteristic anomalies. All tumor cells were hyperdiploid, with a mean chromosome number ranging from 59 to 83, and had many clona
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c329241d2e01a4999f30dccb43adb40
https://doi.org/10.1016/0165-4608(92)90148-2
https://doi.org/10.1016/0165-4608(92)90148-2
Autor:
B. Pellae-Cosset, H. de Cremoux, Benna F, M.L. Cerrina, J. Cueto Ladron de Guevara, H. El Bakry, M. Martin, T. Le Chevalier, Rodrigo Arriagada, Pierre Baldeyrou
Publikováno v:
Radiotherapy and Oncology. 20:91-98
An analysis of the chest recurrences was conducted in 72 consecutive patients with limited small cell lung cancer treated in two successive phase II trials alternating six induction chemotherapy courses and three series of thoracic radiotherapy, foll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0029f3210d3f84ae782156a30598f2a1
https://doi.org/10.1016/0167-8140(91)90142-4
https://doi.org/10.1016/0167-8140(91)90142-4
Autor:
Stéphane Culine, S. Szyldergemajn, Y. Yataghene, Jean Trédaniel, C. Becht, F. Chomy, M. Bekradda, H. de Cremoux, Jérôme Alexandre
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 63(2)
The purpose of this multicentric Phase II study was to evaluate the safety and efficacy of a gemcitabine/oxaliplatin/vinorelbine combination as first-line therapy in advanced non-small cell lung cancer patients. Patients followed a fortnightly drug s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e975b1a0f67ccf3cfbbf1fdbbf2c46a
https://pubmed.ncbi.nlm.nih.gov/18635285
https://pubmed.ncbi.nlm.nih.gov/18635285